Poisoning by organo-phosphorous compounds

Indication for Atropine

Population group: Suitable for both men and women, only minors (0 - 18 years old)

Atropine is used in the treatment of poisoning by certain cholinesterase inhibitors e.g. organo-phosphorous compounds.

For this indication, competent medicine agencies globally authorize below treatments:

50 ug/kg once

Route of admnistration

Intravenous

Defined daily dose

50 - 50 ug per kg of body weight

Dosage regimen

From 50 To 50 ug per kg of body weight once every day

50 ug/kg once

Route of admnistration

Intramuscular

Defined daily dose

50 - 50 ug per kg of body weight

Dosage regimen

From 50 To 50 ug per kg of body weight once every day

Active ingredient

Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system.

Read more about Atropine

Related medicines

Summary of Product Characteristics (SPC) 2016: ATROPINE Eye drops
Summary of Product Characteristics (SPC) 2016: ATROPINE Tablet
Structured Product Labeling (SPL/PLR) 2020: ISOPTO ATROPINE Ophthalmic solution
Summary of Product Characteristics (SPC) 2019: ATROPINE Solution for injection

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner